Site Home   Gender and Cardiovascular Disease       Introduction to Gender and Health   The Gender Lens Tool

References for this Section

1. Amberson, B.L., (2000) Risk Factors and Primary Prevention of Ischemic Heart Disease in Women. Canadian Cardiovascular Society Consensus Conference: Women and Ischemic Heart Disease, October 2000: 4/1-4/25.

2. Abramov, D., Tamariz, M.G., Sever, J.Y., Christakis, G.T., Bhatnagar, G., Heenan, A.L., Goldman, B.S., Fremers, S.E., (2000) The Influence of Gender on the Outcome of Coronary Artery Bypass Surgery. The Society of Thoracic Surgeons, 70:800-6.

3. Stampfer, M.J., Colditz, G.A., Willett, W.C., Menopause and Heart Disease: a Review. Ann N Y Sci, 592:193-203.

4. Ridker PM, Cook NR, Lee I-M, et al. A Randomized trial of Low-Dose Aspirin in the Primary Prevention of Cardiovascular Disease in Women. NEJM 2005;352:1293-1304.

5. Pearson TA, et al. AHA Guidelines for Primary Prevention of Cardiovascular Disease and Stroke: 2002 Update: Consensus Panel Guide to Comprehensive Risk Reduction for Adult Patients Without Coronary or Other Atherosclerotic Vascular Diseases. American Heart Association Science Advisory and Coordinating Committee. Circulation 2002;106:388-91

6. Hansson L, et al. Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial. HOT Study Group.Lancet 1998;351:1755-62

7. de Gaetano G, Collaborative Group of the Primary Prevention Project. Low-dose aspirin and vitamin E in people at cardiovascular risk: a randomised trial in general practice. Collaborative Group of the Primary Prevention Project.Lancet 2001;357:1134

8. Aspirin for the Primary Prevention of Cardiovascular in Women and Men. A Sex-Specific Meta-analysis of Randomized Controlled Trials JAMA 2006;295:306-313

9. Froelicher ESS, et al. High Rates of Sustained Smoking Cessation in Women Hospitalized With Cardiovascular Disease: The Women’s Initiative for Nonsmoking (WINS) Circulation 2004; 109: 587 - 593.

10. Mosca L, et al. Evidence-Based Guidelines for Cardiovascular Disease Prevention in Women. AHA/ACC 2004 Scientific Statement. Circulation 2004;109:672-693.

11. Canadian Diabetes Association Clinical Practice Guidelines Expert Committee. Canadian Diabetes Association 2003 Clinical Practice Guidelines for the Prevention and Management of Diabetes in Canada. Can J Diabetes. 2003;27(suppl 2).

12. Genest J, Frohlich J, Fodor G and McPherson R. Recommendations for the management of dyslipidemia and the prevention of cardiovascular disease: summary of the 2003 update. CMAJ 2003; 169 (9):921 http://www.cmaj.ca/cgi/content/full/169/9/921 accessed March 27, 2006